News Sentiment

FLGT sentiment intelligence

Fulgent Genetics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 60 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 20.55 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 60

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend inactive

-1.4% over one week, +10.0% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Fulgent Genetics seen as undervalued with strong balance sheet and insider buying, rated soft Buy.

Market Reaction

Balanced read

58/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction -1.4% Price digesting
Trend fit Trend inactive 10.0% over four weeks
Fair value -7.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 48
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 60
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 11
Stock Titan 6
TradingKey 6
Market source 5
Business Wire 4
Seeking Alpha 3
Stock Traders Daily 3
simplywall.st 3

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 19
Analyst action 6
Guidance 2
Capital return 1
Regulatory and legal 1
Deals and strategy 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 60
Investing.com Direct company coverage

Fulgent Genetics CSO Gao Hanlin sells $30,190 in stock

Fulgent Genetics Chief Scientific Officer Gao Hanlin sold 1,688 shares of company stock worth $30,190 to cover tax withholding obligations. Following the sale, Hanlin still holds 990,374 shares. The company recently reported lower-than-expected Q1 2026 earnings and revenue but ho

Tone
Negative 41/100
Event
Earnings
Published
03 Jun 2026 21:40
Source
Investing.com
Stock Titan Direct company coverage

Fulgent Genetics (NASDAQ: FLGT) insider sale covers RSU taxes

Fulgent Genetics President and COO Jian Xie sold 2,146 shares of common stock on June 2, 2026, at a weighted-average price of $17.8855 per share. This sale was conducted to cover tax withholding obligations associated with the vesting of restricted stock units granted in February

Tone
Neutral 50/100
Event
Market update
Published
03 Jun 2026 21:39
Source
Stock Titan
Stock Titan Direct company coverage

Fulgent Genetics (FLGT) CSO sells 1,688 shares to cover RSU tax

Fulgent Genetics' Chief Scientific Officer, Hanlin Gao, sold 1,688 shares of common stock at a weighted-average price of $17.8855 per share. This sale was conducted to satisfy tax withholding obligations arising from the vesting of previously granted restricted stock units. Follo

Tone
Neutral 50/100
Event
Market update
Published
03 Jun 2026 21:39
Source
Stock Titan
Stock Titan Direct company coverage

Fulgent Genetics (FLGT) CFO reports tax withholding of vested RSU shares

Fulgent Genetics (FLGT) CFO Paul Kim reported a routine share disposition where 2,087 shares of common stock were withheld at $18.09 per share to cover tax obligations from the vesting of restricted stock units. This was a non-market event related to compensation, not an open-mar

Tone
Neutral 50/100
Event
Market update
Published
03 Jun 2026 21:39
Source
Stock Titan
Stock Titan Direct company coverage

Fulgent Genetics (NASDAQ: FLGT) Form 144 lists 45,304 vested shares; small prior sale

Fulgent Genetics (NASDAQ: FLGT) filed a Form 144 indicating the intended resale of 45,304 restricted common shares that vested on February 25, 2025. The filing also disclosed a prior sale of 1,201 shares on May 27, 2026, by Jian Xie, with Morgan Stanley Smith Barney LLC listed as

Tone
Neutral 50/100
Event
Market update
Published
03 Jun 2026 01:09
Source
Stock Titan
Los Angeles Business Journal Direct company coverage

Fulgent Moves Beyond Covid

Tone
Neutral 50/100
Event
Market update
Published
28 Aug 2023 07:00
Source
Los Angeles Business Journal